Clinical trial Recruiting at 1 site Interventional Ages 1 Minute to 2 Minutes

Evaluating methods to improve outcomes for premature babies through placental transfusion techniques

Official title: Evaluation of Placental Transfusion Techniques in of Prematurity Related Complications and Hematological Profile

Run by Alexandria University · NCT06812507 · Data updated 2026-11-12

This study is testing different ways to give blood from the placenta to premature babies to see which method helps them stay healthier in their first days of life.

Quick facts

Study typeInterventional
Ages1 Minute to 2 Minutes
SexAll
Enrollment160 (estimated)
SponsorAlexandria University
Academic / other
Locations1 site (Alexandria)
StatusRecruiting
StartedMarch 10, 2025
Main results expectedMarch 28, 2026
Study endsApril 28, 2026
Registry record updatedJanuary 16, 2026
Trial IDNCT06812507 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are premature neonates born at or before 32 weeks of gestation who will be admitted to a neonatal intensive care unit within their first day of life.

Probably not a fit

Patients who are born after 32 weeks of gestation or have major congenital anomalies will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to assess the effectiveness of different placental transfusion methods, including intact umbilical cord milking, cut umbilical cord milking, and delayed cord clamping, in preventing complications associated with prematurity in neonates. The research will monitor premature infants born at or before 32 weeks of gestation during their initial days of life in a neonatal intensive care unit. By comparing these techniques, the study seeks to determine which method may provide the best outcomes for these vulnerable patients.

Why it matters

Potential benefit: If successful, this study could lead to improved health outcomes and reduced complications for premature infants.

How similar studies have gone: Other studies have shown promising results with similar placental transfusion techniques, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
* Inclusion Criteria:

  1. Premature neonates ≤ 32 weeks gestational age regardless birth weight
  2. patients should be admitted to neonatal intensive care unit in the first day of life of life

Exclusion criteria:

* Exclusion Criteria:

Patient with any of the following will be excluded:

1. Major congenital anomalies (complex cyanotic heart disease, major central nervous system anomalies).
2. Evidence of head trauma causing major intracranial hemorrhage.
3. placental abnormalities like : abruptions, placenta previa or retroplacental hematoma.
4. Cord accident, or avulsion at the time of delivery.
5. Refusal to perform the intervention by the obstetrician

Where it's running

  • Marwa Mohamed Farag
    Alexandria, Egypt
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.